Home > Insider Trading > Filing (0001144204-16-137893)

Filing Details

Accession Number:: 0001144204-16-137893
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-12-05 16:11:55
Reporting Period:: 2016-12-01

Filing Date:: 2016-12-05
Accepted Time:: 2016-12-05 16:11:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1279695	Universal Biosensors Inc	UBI	Surgical & Medical Instruments & Apparatus (3841)	980424072

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1679282	Fund Conviction High Vf	31 Carrington Street Nedlands C3 6009		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-12-01	1,807,004	$0.32	9,404,933	No	4	P	Direct
Common Stock	Acquisiton	2016-12-02	165,000	$0.32	9,569,933	No	4	P	Direct
Common Stock	Acquisiton	2016-12-02	154,736	$0.32	9,724,669	No	4	P	Direct
Common Stock	Acquisiton	2016-12-05	112,009	$0.33	9,836,678	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2950 to $0.3200, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price per share of the common stock reported is stated in Australian dollars, as converted from a U.S. dollar price on the date of the transaction.
The common stock is directly held by VF High Conviction Fund ("Conviction Fund") and indirectly held by Viburnum Funds Pty Ltd ("Viburnum"), the manager of Conviction Fund, and the individual directors of Viburnum (Viburnum and the individual directors together, the "Viburnum Indirect Reporting Persons"). The individual directors of Viburnum are Craig Coleman, Marshall Allen, Anthony Howarth and Melissa Karlson. The Viburnum Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Conviction Fund common stock in which the Viburnum Indirect Reporting Persons have no pecuniary interest.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3200 to $0.3300, inclusive. The Reporting Person undertakes to provide to UBI, any security holder of UBI, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.